Showing results (81-90 of 261) with videos related to
Sort By:
Pageof 27
Bone Marrow Transplantation|September 1, 2009
Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioningE Willems, F Baron, L Seidel, et al.Revue Medicale De Liege|January 15, 1999
[Clinical case of the month. The association of Hodgkin's disease and nephrotic syndrome]F Baron, J P Hermanne, M F Fassotte, et al.Revue Medicale De Liege|January 21, 2010
[Immune recovery following allogeneic hematopoietic cell transplantation]E Castermans, M Hannon, P Drion, et al.The Journal of Laboratory and Clinical Medicine|March 1, 1989
Hepatocyte iron release in ratsY Beguin, H A Huebers, G Weber, et al.Leukemia|December 1, 1993
Soluble CD23 and other receptors (CD4, CD8, CD25, CD71) in serum of patients with chronic lymphocytic leukemiaY Beguin, S Lampertz, D De Groote, et al.Acta Haematologica|January 1, 1988
Ferrokinetic measurement of erythropoiesisY Beguin, S M Stray, M Cazzola, et al.Revue Medicale De Liege|August 1, 2009
[Monoclonal antibodies in hematology in 2009]C Bonnet, Y Beguin, B De Prijck, et al.Revue Medicale De Liege|August 30, 2007
[Current therapies in hematology]B De Prijck, F Baron, Y Beguin, et al.Bone Marrow Transplantation|January 12, 2010
Elevations of tumor necrosis factor receptor 1 at day 7 and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioningE Willems, S Humblet-Baron, O Dengis, et al.Revue Medicale De Liege|June 3, 2021
[Diffuse large B-cell lymphoma: a revolutionary treatment based on genetically-modified immune cells called CAR T cells]C Maquet, Y Beguin, B De Prijck, et al.Pageof 27